Fig. 8. Quantification of single EVs in mixed human and mouse PPP samples.
Samples were stained with CFDA-SE and anti-human and anti-mouse CD31 (conjugated to BV421 and APC, respectively). Quantification of (a) CFSE + anti-human CD31 + single EV ≤ 400 nm showed a linear increase corresponding to the increase in human PPP abundance (R2 = 0.95), while (b) CFSE + anti-mouse CD31 + single EV ≤ 400 nm showed a linear decrease corresponding to the decrease in mouse PPP abundance (R2 = 0.81). Data were obtained through three independent experiments using the same human and mouse PPP samples. X-axis: v/v ratio of mouse – human PPP. Data shown represent the mean ± standard error. Red dashed lines: background concentrations of our protocol as indicated by the measurement of isotype controls.